- Home
- DBI vs FDMT Comparison
DBI vs FDMT Comparison
Compare DBI & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- FDMT
- Stock Information
- Founded
- DBI 1991
- FDMT 2013
- Country
- DBI United States
- FDMT United States
- Employees
- DBI N/A
- FDMT N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- DBI Consumer Discretionary
- FDMT Health Care
- Exchange
- DBI Nasdaq
- FDMT Nasdaq
- Market Cap
- DBI 161.1M
- FDMT 192.2M
- IPO Year
- DBI 1991
- FDMT 2020
- Fundamental
- Price
- DBI $2.87
- FDMT $4.41
- Analyst Decision
- DBI Hold
- FDMT Buy
- Analyst Count
- DBI 2
- FDMT 10
- Target Price
- DBI $3.50
- FDMT $32.33
- AVG Volume (30 Days)
- DBI 1.2M
- FDMT 276.3K
- Earning Date
- DBI 09-10-2025
- FDMT 08-07-2025
- Dividend Yield
- DBI 7.02%
- FDMT N/A
- EPS Growth
- DBI N/A
- FDMT N/A
- EPS
- DBI N/A
- FDMT N/A
- Revenue
- DBI $2,949,575,000.00
- FDMT $23,000.00
- Revenue This Year
- DBI N/A
- FDMT $11,586.49
- Revenue Next Year
- DBI $2.45
- FDMT N/A
- P/E Ratio
- DBI N/A
- FDMT N/A
- Revenue Growth
- DBI N/A
- FDMT N/A
- 52 Week Low
- DBI $2.18
- FDMT $2.24
- 52 Week High
- DBI $8.45
- FDMT $18.14
- Technical
- Relative Strength Index (RSI)
- DBI 45.82
- FDMT 52.88
- Support Level
- DBI $2.67
- FDMT $4.27
- Resistance Level
- DBI $3.41
- FDMT $4.75
- Average True Range (ATR)
- DBI 0.21
- FDMT 0.24
- MACD
- DBI 0.01
- FDMT -0.00
- Stochastic Oscillator
- DBI 23.81
- FDMT 43.48
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.